International medical diagnostics company Panbio Limited today announced that it had developed two prototype immunoassays using their proprietary panDA Homogeneous Assay technology.Panbio’s prototype panDA Homogeneous Assays are able to specifically and accurately detect and differentiate IgG antibodies induced by infection with Herpes Simplex Virus (HSV) 1 and HSV 2 in validated serum samples.>>> Discuss This Story
